ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $938,000 | +22.6% | 139,400 | 0.0% | 0.10% | -4.7% |
| Q3 2014 | $765,000 | -46.5% | 139,400 | 0.0% | 0.11% | -44.8% |
| Q2 2014 | $1,429,000 | -14.6% | 139,400 | 0.0% | 0.19% | -25.4% |
| Q1 2014 | $1,674,000 | +179.5% | 139,400 | +163.0% | 0.26% | +40.5% |
| Q4 2013 | $599,000 | – | 53,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |